Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Antengene Discovery Limited
Scientific Title
A Phase I, Open-Label, Multi-Center, Dose Finding Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of ATG-018 (ATR Inhibitor) Treatment in Patients With Advanced Solid Tumors and Hematological Malignancies